The conventional RAS (ACE/Ang II/AT1R) axis activation in parallel with non-conventional (ACE2/Ang 1-7/Mas) axis down-regulation was proposed to be the underlying factors leading to severe COVID-19 outcome in hypertension (Lanza et al., 2020; Vieira et al., 2021). The gene discussed is ACE2; the disease is COVID-19.